Perceptive Advisors - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$527,000
+235.7%
100,000
+400.0%
0.05%
+283.3%
Q4 2015$157,000
-53.6%
20,000
-50.0%
0.01%
-14.3%
Q3 2015$338,000
-24.7%
40,000
-2.4%
0.01%
-48.1%
Q2 2015$449,000
-47.4%
41,000
-32.8%
0.03%
-59.1%
Q1 2015$853,000
+229.3%
61,000
+298.1%
0.07%
+200.0%
Q4 2014$259,000
-94.6%
15,323
-95.6%
0.02%
-96.2%
Q4 2013$4,834,000
-29.0%
350,000
-10.3%
0.58%
+107.5%
Q3 2013$6,804,000
+275.3%
390,310
+248.7%
0.28%
+53.0%
Q2 2013$1,813,000111,9400.18%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders